Paul F Corey

This inventor holds 26 USPTO granted patents, plus 9 CIPO patents and 1 EPO patent, primarily in Diagnostic Devices. Top assignees: Miles Inc., Bayer Corporation, Miles Laboratories, Inc.. Active years: 1985-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul F Corey. Retrieved from https://idiyas.com/inventor/paul-f-corey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 96.2

CIPO Patents = 9 (Patent Applications = 9)

EPO Patents = 1

Average Co-Inventor Count = 1.7

ph-index = 10

Forward Citations = 704(Granted Patents)

Location History:

Del Mar, CA (US) (1989)
Elkart, IN (US) (1993)
Elkhart, IN (US) (1985 - 2006)

Company Filing History:

Miles Laboratories, Inc.

patents

4. 1 out of 834,453

Other

patents

Years Active: 1985-2006

Loading Chart...

Areas of Expertise:

Trypsin Assays

Electrochemical Mediators

Chromogenic Substrates

Diagnostic Devices

Liquid Samples

Error Indicators

Hydrolytic Analytes

Test Strips

NADH Regeneration

Arylazo Compounds

Enzyme Substrates

Pyrrole Compounds

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7001737 - Urinary trypsin inhibitor assay containing a chelating agent (2006-02-21),

2. 6955921 - Trypsin substrate and diagnostic device, and method of using same (2005-10-18),

3. 6770764 - Trypsin substrate and diagnostic device, and method of using same (2004-08-03),

4. 6316264 - Test strip for the assay of an analyte in a liquid sample (2001-11-13),

5. 5520786 - Mediators suitable for the electrochemical regeneration of NADH, NADPH (1996-05-28),

6. 5498542 - Electrode mediators for regeneration of NADH and NADPH (1996-03-12),

7. 5393615 - Mediators suitable for the electrochemical regeneration of NADH, NADPH (1995-02-28),

8. 5328850 - Merocyanine protein error indicators (1994-07-12),

9. 5310888 - Arylazo chromoionophores (1994-05-10),

10. 5279790 - Merocyanine and nitro or nitroso substituted polyhalogenated (1994-01-18),

11. 5264589 - Merocyanine protein error indicators (1993-11-23),

12. 5208326 - 8-hydroxy-2H-dibenz(b,f)azepin-2-one dyes (1993-05-04),

13. 5191073 - Chromogenic merocyanine enzyme substrates (1993-03-02),

14. 5187104 - Nitro or nitroso substituted polyhalogenated phenolsulfonephthaleins as (1993-02-16),

15. 5183743 - Chromogenic dibenzoxazepinone and dibenzothiazepinone enzyme substrates (1993-02-02),

Title: Paul F. Corey: Innovator in Diagnostic Technologies

Introduction: Paul F. Corey, based in Elkhart, Indiana, is a prolific inventor known for his significant contributions to the field of diagnostics. With a remarkable portfolio of 25 patents, Corey has dedicated his career to developing innovative solutions that enhance clinical diagnostics and patient care.

Latest Patents: Among his recent inventions, Corey's patented methods for urinary trypsin inhibitor assays stand out. One notable invention is the "Urinary trypsin inhibitor assay containing a chelating agent," which provides a reliable way to determine the concentration of trypsin inhibitor in urine samples. By incorporating a polycarboxylic chelating agent, this assay effectively minimizes variations in results, improving diagnostic accuracy. Another of Corey’s significant patents is for a "Trypsin substrate and diagnostic device," offering a novel method to detect levels of urinary trypsin inhibitor in biological samples. His advancements include a diagnostic kit designed to streamline this detection process.

Career Highlights: Corey's career includes pivotal roles at major corporations such as Miles Inc. and Bayer Corporation. His work at these esteemed companies allowed him to collaborate with leading experts and contribute to cutting-edge research in diagnostics.

Collaborations: Throughout his career, Corey has worked alongside esteemed colleagues, notably Michael J. Pugia and Gary E. Rehm. These collaborations have played a crucial role in the development and realization of his innovative patents, combining expertise to drive impactful advancements in medical diagnostics.

Conclusion: Paul F. Corey’s contributions to the field of diagnostic innovations underscore his status as a key inventor in the industry. With a robust portfolio of patents and a commitment to improving healthcare through precise diagnostic methods, Corey continues to influence the realm of medical technologies.

Profile summary based on public USPTO records.